Excited delirium syndrome

TASER® Conducted Electrical Weapons: Physiology, Pathology, and Law

Volumn , Issue , 2009, Pages 347-363

  Di Maio, Vincent J M ^a   Di Maio, Theresa G ^b  

^a NONE   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

EID: 79955837164     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/978-0-387-85475-5_28     Document Type: Chapter

References (47)

1. American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders, 4th ed. Text Revision. Washington, DC: American Psychiatric Association, 2000.
2. Di Maio T. G. and Di Maio V. J. M. Excited Delirium Syndrome. Boca Raton, FL: CRC Press Inc., 2006.
3. Bell L. V. On a Form of Disease resembling some advanced stages of mania and fever. Amer. J. Insanity 6:97-127, 1849.
4. Cancro R. The Introduction of Neuroleptics: A Psychiatric Revolution. Psychiatric Services 51(3), 2000.
5. Lieberman J. A., Golden R., Stroup S., and McEnvoy J. Drugs of the psychopharmacological revolution in clinical psychiatry. Psychiatric Services 51(10), 2000.
6. Di Maio V. J. M. and Di Maio, D. Forensic Pathology, 2nd ed. Boca Raton, FL: CRC Press Inc., 2001.
7. Stratton S. J., Rogers C., Brickett, K., and Gruzinski G. Factors associated with sudden death of individuals requiring restraint for excited delirium. Amer. J. Emerg. Med. 19(3):187-191, 2001.
8. Weiss S. and Baker J. P. The carotid sinus reflex in health and disease. Medicine 12:297-354, 1933.
9. Thomas J. E. Hyperactive carotid sinus reflexes and carotid sinus syncope. Mayo Clinic. Proc. 44:127-139, 1969.
10. Walter P. F., Crawley I. S., and Dorney E. R. Carotid sinus hyppersensitivity and syncope. Amer. J. Cardiology. 42:396-403, 1978.
11. Reay D. T., Howard J. D., Fligner C. L., and Ward, R. J. Effects of positional restraint on oxygen saturation and heart rate following exercise. Amer J. Forensic Med. Path. 9(1):16-18, 1988.
12. O'Halloran R. L. and Lewman L. V. Restraint asphyxiation in excited delirium. Am. J. Forensic Med. Pathol. 14(4):289-295, 1993.
13. Chan T. C., Vilke G. M., Neuman T., and Clausen L. Restraint positional asphyxia. Ann. Emerg. Med. 1997;30(5):578-586.
14. Michalewicz B. A., Chan T. C., Vilke G. M., Levy S. S., Neuman T. S., and Kolkhorst F. W. Ventilatory and metabolic demands during aggressive physical restraint in healthy adults. J. Forensic Sci. 52(1):171-175, 2007.
15. Guyton A. C. and Hall J. E. Medical physiology, 10th ed. Philadelphia: WB Saunders, 2000.
16. World Health Organization. Neuroscience of Psychoactive Substance Use and Dependence, 2004.
17. Cooper J. R., Bloom F. E., and Roth R. H. The Biochemical Basis of Neuropharmacology, 8th ed. New York: Oxford University Press, 2003.
18. Katz A. M. Physiology of the heart. Philadelphia, PA: Lippincott Williams & Wilkins, 2001.
19. Insel PA. Seminars in medicine of the Beth Israel Hosp., Boston: Adrenergic receptors - evolving concepts and clinical implications (Review article). New Eng. J. Med. 334(9):580-585, 1996.
20. Calzada B. C. and De Artinano A. A. Alpha-adrenoceptor subtypes. Pharm. Res. 44(3):195-208, 2001.
21. Guimaraes S. and Moura D. Vascular adrenoceptors: an update. Pharm. Reviews. 53:319-356, 2001.
22. Heusch G., Baumgart D., Camici P., et al. [alpha]-Adrenergic coronary vasoconstriction and myocardial ischemia in humans. Circulation 101(6):689-694, 2000.
23. Lange R. A. and Hillis L. D. Cardiovascular complications of cocaine use. New Eng. J. Med. 345(5):351-358, 2001.
24. Hajjar R. J. and MacRae C. A. Editorial "Adrenergic-receptor polymorphism and heart failure. New Eng. J. Med. 347(15):1196-1198, 2002.
25. 2c adrenergic receptors and the risk of congestive heart failure. New Eng. J. Med. 347(15):1135-1142, 2002.
26. Dimsdale J. E., Hartley G. T., Guiney T., Ruskin J. N., and Greenblatt D. Post-exercise peril: Plasma catecholamines and exercise. JAMA 251:630-632, 1984.
27. Young D. B., Srivastava T. N., Fitzovich D. E., Kivlighn S. D., and Hamaguchi M. Potassium and catecholamine concentrations in the immediate post exercise period. Am. J Med. Sci. 304:150-153, 1992.
28. Rastergar A. and Soleimani M. Hypokalaemia and hyperkalaemia. Postgrad Med J. 77:759-764, 2001.
29. Gennar F. J. Current concepts: Hypokalemia (review article). New Eng. J. Med. 339(7):451-458, 1998.
30. Medbo J. I. and Sejersted O. M. Plasma potassium changes with high intensity exercise. J Physiol. 421:105-122, 1990.
31. Lindinger M. I. Potassium regulation during exercise and recovery in humans: implications for skeletal and cardiac muscle. J. Mol. Cell. Cardiol. 27(4):1011-1022, 1995.
32. Paterson D. J., Rogers J., Powell T., and Brown H. F. Effect of catecholamines on the ventricular myocyte action potential in raised extracellular potassium. Acta Physiologica. Scand. 148:177-186, 1993.
33. Leitch S. P. and Paterson D. J. Interactive effects of K+, acidosis, and catecholamines on isolated rabbit heart: implications for exercise. J. Appl. Physiol. 77(3):1164-1171, 1994.
34. Karch S. B., Green G. S., et al. Myocardial hypertrophy and coronary artery disease in male cocaine users. J. Forensic Sci. 40(4):591-595, 1995.
35. Wiener R. S., Lockhart J. T., and Schwartz R. G. Dilated cardiomyopathy and cocaine abuse: report of two cases. Amer. J. Med. 81:699-701, 1986.
36. Karch S. B. Karch's Pathology of Drug Abuse, 3rd. ed. Boca Raton, FL: CRC Press, 2002.
37. Silver M. D., Gotlieb A. L., and Schoen F. J. Cardiovascular Pathology. Philadelphia, PA: Churchill Livingstone, 2001.
38. Spitito P., Bellone P., et al. Magnitude of left ventricular hypertrophy and risk of sudden death in hypertrophic cardiomyopathy. New Eng. J. Med. 342(24):1778-1785, 2000.
39. Staley J. K., Hearn W. L., Ruttenber A. J., Wetli C. V., and Mash D. C. High affinity cocaine recognition sites on the dopamine transporter are elevated in fatal cocaine overdose victims. J. Pharmacol. Exp. Ther. 271:1678-1685, 1994.
40. Mash D. C., Pablo J., Ouyang Q., Hearn W. L., and Izenwasser S. Dopamine transport function is elevated in cocaine users. J. Neurochem. 81:292-300, 2002.
41. Billman G. E. Cocaine: a review of the toxic actions on cardiac function. Crit Rev. Toxicol. 25:113, 1995.
42. Fleckenstein A. E., Gibb J. W., Hanson G. R. Differential effects of stimulants on monoaminergic transporters: pharmacological consequences and implications for neurotoxicity. Eur. J. Pharmacol. 406(1):1-13, 2000.
43. McCann U. D. and Ricaurte G. A. Amphetamine neurotoxicity: accomplishments and remaining challenges. Neurosci. Biobehavioral Rev. 27(8):821-826, 2004.
44. Singer K. and Lundberg W. B. Ventricular arrythmias associated with the ingestion of alcohol. Ann. Intern. Med. 77:247-248, 1972.
45. Ettinger P. O., Wu C. F., De La Cruz C. Jr., Weisse A. B., Ahmed S. S., and Regan T. J. Arrhythmias and the "Holiday Heart": alcohol-associated cardiac rhythm disorders. Am. Heart J. 95(5):555-562, 1978.
46. Witchel H. J., Hancox J. C., and Nutt D. J. Psychotropic drugs, cardiac arrhythmia, and sudden death. J. Clin. Psychopharmacol. 23(1):58-77, 2003.
47. Roden D. M. Drug-induced prolongation of the QT interval] New Eng. J. Med. 350(10):1013-1022, 2004.